Citadel Advisors
PMI

Citadel Advisors’s Picard Medical PMI Stock Holding History

Citadel Advisors’s Portfolio PMI Stock Details PMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-204,154
Closed -$1.74M – 14680
2025
Q3 		$1.74M Buy
+204,154
New +$1.44M ﹤0.01% 6367

Other funds holding PMI

AC
Aristides Capital Louisville, Kentucky $462M AUM 28.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $469M AUM 34.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WMP
Wealth Management Partners Tucson, Arizona $350M AUM 39.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors's PMI Position: Q4 2025 in Review

Citadel Advisors sold out of Picard Medical (PMI) in Q4 2025, closing a stake of 204,154 shares — an estimated $1.74M sold.

Citadel Advisors first reported a position in PMI in Q3 2025 and held it in 1 quarter. The position peaked at $1.74M in Q3 2025. 31 funds tracked by Wall St. Rank hold PMI as of Q4 2025.

  • Citadel Advisors reported no remaining Picard Medical position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 204,154 Picard Medical shares in Q4 2025, an estimated $1.74M.
  • Citadel Advisors first reported a position in Picard Medical in Q3 2025 and held it in 1 quarter.
  • Citadel Advisors's Picard Medical position peaked at $1.74M in Q3 2025.
  • 31 funds tracked by Wall St. Rank held Picard Medical as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.